670 related articles for article (PubMed ID: 29429177)
41. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
[TBL] [Abstract][Full Text] [Related]
42. Induction chemotherapy followed by concurrent chemoradiation versus concurrent chemoradiation alone in the definitive management of p16-positive oropharyngeal squamous cell carcinoma with low-neck or N3 disease.
Bhattasali O; Han J; Thompson LDR; Buchschacher GL; Abdalla IA; Iganej S
Oral Oncol; 2018 Mar; 78():151-155. PubMed ID: 29496043
[TBL] [Abstract][Full Text] [Related]
43. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
[TBL] [Abstract][Full Text] [Related]
44. The Extent of Neck Dissection Among Patients Who Receive Adjuvant Radiotherapy for HNSCC and Its Effect on Disease-Specific and Overall Survival.
Aboelkheir UM; Iovoli AJ; Platek AJ; Wang C; Hermann GM; Magner WJ; Platek ME; Singh AK; Gupta V; Hicks WL; Arshad H
Ear Nose Throat J; 2019; 98(4):227-231. PubMed ID: 30943803
[TBL] [Abstract][Full Text] [Related]
45. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.
Corry J; Bressel M; Fua T; Herschtal A; Solomon B; Porceddu SV; Wratten C; Rischin D
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):948-954. PubMed ID: 28483336
[TBL] [Abstract][Full Text] [Related]
46. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
47. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Haddad R; O'Neill A; Rabinowits G; Tishler R; Khuri F; Adkins D; Clark J; Sarlis N; Lorch J; Beitler JJ; Limaye S; Riley S; Posner M
Lancet Oncol; 2013 Mar; 14(3):257-64. PubMed ID: 23414589
[TBL] [Abstract][Full Text] [Related]
48. Lymph node ratio as a prognostic factor in head and neck cancer patients.
Chen CC; Lin JC; Chen KW
Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
[TBL] [Abstract][Full Text] [Related]
49. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience.
Lavertu P; Adelstein DJ; Saxton JP; Secic M; Eliachar I; Strome M; Larto MA; Wood BG
Arch Otolaryngol Head Neck Surg; 1999 Feb; 125(2):142-8. PubMed ID: 10037279
[TBL] [Abstract][Full Text] [Related]
50. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
[TBL] [Abstract][Full Text] [Related]
51. Nodal volume as a prognostic factor in locally advanced head and neck cancer: Identifying candidates for elective neck dissection after chemoradiation with IGRT from a single institutional prospective series from the Indian subcontinent.
Dua B; Chufal KS; Bhatnagar A; Thakwani A
Oral Oncol; 2018 Dec; 87():179-185. PubMed ID: 30527237
[TBL] [Abstract][Full Text] [Related]
52. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
[TBL] [Abstract][Full Text] [Related]
53. [Analyses of clinicopathologic factors affecting neck control after postoperative radiation as adjuvant treatment for lymph node metastasis in head and neck squamous cell carcinoma].
Di B; Li XM; Zhang JJ; Liu S; Song Q; Tao ZF; Fan C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jul; 51(7):485-90. PubMed ID: 27480295
[TBL] [Abstract][Full Text] [Related]
54. Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
Mitsudo K; Koizumi T; Iida M; Iwai T; Oguri S; Yamamoto N; Itoh Y; Kioi M; Hirota M; Tohnai I
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e639-45. PubMed ID: 22543212
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of extracapsular spread in isolated neck recurrences in head and neck squamous cell carcinoma patients.
León X; Rigó A; Farré N; López M; García J; de Juan J; Quer M
Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):527-533. PubMed ID: 27509897
[TBL] [Abstract][Full Text] [Related]
56. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
Mehanna H; Wong WL; McConkey CC; Rahman JK; Robinson M; Hartley AG; Nutting C; Powell N; Al-Booz H; Robinson M; Junor E; Rizwanullah M; von Zeidler SV; Wieshmann H; Hulme C; Smith AF; Hall P; Dunn J;
N Engl J Med; 2016 Apr; 374(15):1444-54. PubMed ID: 27007578
[TBL] [Abstract][Full Text] [Related]
57. Selective neck dissection in node-positive squamous cell carcinoma of the head and neck.
Givi B; Linkov G; Ganly I; Patel SG; Wong RJ; Singh B; Boyle JO; Shaha AR; Shah JP; Kraus DH
Otolaryngol Head Neck Surg; 2012 Oct; 147(4):707-15. PubMed ID: 22517013
[TBL] [Abstract][Full Text] [Related]
58. N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?
Cho AH; Shah S; Ampil F; Bhartur S; Nathan CO
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1112-8. PubMed ID: 19917924
[TBL] [Abstract][Full Text] [Related]
59. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx.
Yom SS; Machtay M; Biel MA; Sinard RJ; El-Naggar AK; Weber RS; Rosenthal DI
Am J Clin Oncol; 2005 Aug; 28(4):385-92. PubMed ID: 16062081
[TBL] [Abstract][Full Text] [Related]
60. Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.
Loo SW; Geropantas K; Beadsmoore C; Montgomery PQ; Martin WM; Roques TW
Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):512-7. PubMed ID: 21501953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
